JANUS HENDERSON GROUP PLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 181 filers reported holding PTC THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.7%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$68,847,799
-52.9%
3,072,320
-14.6%
0.04%
-50.5%
Q2 2023$146,296,747
-5.5%
3,596,750
+12.5%
0.09%
-10.8%
Q1 2023$154,839,364
+100.1%
3,196,304
+57.7%
0.10%
+85.5%
Q4 2022$77,374,244
-25.9%
2,027,142
-51.2%
0.06%
-29.5%
Q3 2022$104,420,316
+22.0%
4,155,728
+94.6%
0.08%
+32.2%
Q2 2022$85,563,000
-14.5%
2,135,676
-20.4%
0.06%
+22.9%
Q1 2022$100,070,000
-35.6%
2,681,974
-31.3%
0.05%
-26.2%
Q4 2021$155,397,000
+16.8%
3,901,397
+9.1%
0.06%
+12.1%
Q3 2021$133,035,000
-10.2%
3,575,187
+2.0%
0.06%
-7.9%
Q2 2021$148,107,000
+1.9%
3,503,914
+14.2%
0.06%
-4.5%
Q1 2021$145,324,000
-20.5%
3,069,140
+2.4%
0.07%
-22.4%
Q4 2020$182,875,000
+93.8%
2,996,421
+48.4%
0.08%
+73.5%
Q3 2020$94,367,000
+2.4%
2,018,563
+11.1%
0.05%
-5.8%
Q2 2020$92,184,000
+16.8%
1,816,811
+2.7%
0.05%
-3.7%
Q1 2020$78,949,000
+10.6%
1,769,757
+19.0%
0.05%
+45.9%
Q4 2019$71,404,000
+56.0%
1,486,662
+9.9%
0.04%
+48.0%
Q3 2019$45,769,000
-26.9%
1,353,305
-2.7%
0.02%
-26.5%
Q2 2019$62,591,000
+17.2%
1,390,918
-1.9%
0.03%
+13.3%
Q1 2019$53,392,0001,418,4790.03%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders